Sofosbuvir Impurity 54 | CAS 16731-31-0 - Request Quote
Sofosbuvir Impurity 54
| SZ CAT No: | SZ-S010077 |
| CAS No | 16731-31-0 |
| Mol.F. | C9H10N2O6 |
| Mol.Wt. | 242.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sofosbuvir Impurity 54 is chemically 1-((2R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-oxotetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione. Sofosbuvir Impurity 54 is supplied with detailed characterization data compliant with regulatory guideline. Sofosbuvir Impurity 54 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sofosbuvir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 16731-31-0
Purchase 16731-31-0
Order 16731-31-0
Enquire 16731-31-0
price of 16731-31-0
16731-31-0 Supplier
16731-31-0 Manufacturer
16731-31-0 Exporter
buy high quality Sofosbuvir Impurity 54
Purchase Sofosbuvir Impurity 54
Sofosbuvir Impurity 54 suppliers
Sofosbuvir Impurity 54 manufacturers
Sofosbuvir Impurity 54 price
Order Sofosbuvir Impurity 54
Enquire Sofosbuvir Impurity 54
Sofosbuvir Impurity 54 cost
Sofosbuvir Impurity 54 Supplier
Sofosbuvir Impurity 54 Distributor
Sofosbuvir Impurity 54 for Method Validation
Sofosbuvir Reference Standard
Sofosbuvir Impurity 54 for ANDA Filing
Sofosbuvir Impurity 54 for Forced Degradation Studies
Sofosbuvir Impurity 54 Identification Standards
Sofosbuvir Impurity 54 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.